DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT01472432

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01472432
Other papers using this trial's data
  • Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes Experimental diabetes research, 2012 DOI, PubMed 23197976, PMC3503302 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01472432. Randomized; double masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2016-01 (actual). Results posted on 2015-06-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
Condition
Chronic Foot Ulcers
Intervention (Drug)
Placebo
Intervention (Drug)
vildagliptin
Lead sponsor
University of Campania Luigi Vanvitelli (class: other)

Record details

Record id
cardio:ct-nct01472432
Content hash
3ef20663f650201ed3da89cdcffba52f5fa09e67b1b15bbb6ad514d1b00a4893